Influence of Renin-Angiotensin System Inhibitors on Lower-Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.
Timothy M E DavisWendy A DavisPublished in: Diabetes care (2020)
ACEi/ARB reduce the risk of pneumonia/influenza in people with type 2 diabetes.